Skip to content

Light therapy applied to the wrist of patients with sepsis or septic shock: A clinical study

Transcutaneous Photobiomodulation over the Radial Artery in Patients with Sepsis or Septic Shock: Randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5k8dfz3
Enrollment
30
Registered
2026-07-14
Start date
2026-04-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shock Septic Sepsis

Interventions

This is a two-arm, double-blind, randomized controlled clinical trial to be conducted in an adult intensive care unit with patients diagnosed with sepsis or septic shock. Patients will be allocated to

Sponsors

Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP)
Lead Sponsor
Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP)
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Both sexes; Over 18 years of age; Diagnosis of sepsis or septic shock according to the criteria defined by the American Society of Critical Care Conference, according to the Sequencial Organ Failure Assessment (SOFA) tool

Exclusion criteria

Exclusion criteria: Those who do not meet the inclusion criteria; Patients with coagulopathies; Severe neurological diseases; Prior use of photobiomodulation therapies; Individuals with extensive lesions or infections in the application area

Design outcomes

Primary

MeasureTime frame
An improvement in peripheral oxygenation is expected in patients with sepsis or septic shock, verified by pulse oximetry, based on the observation of variations in pre- and post-intervention measurements after seven days of application of transcutaneous photobiomodulation over the radial artery

Secondary

MeasureTime frame
Assess the reduction of serum concentrations of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-a) after transcutaneous photobiomodulation, analyzed through laboratory tests;To assess the effect of transcutaneous photobiomodulation on stabilizing the hemodynamic parameters of patients with sepsis or septic shock during the follow-up period, analyzed through patient monitoring;Assess the reduction of serum lactate levels after applying transcutaneous photobiomodulation, analyzed through routine laboratory tests;Assess the evolution of the Sequential Organ Failure Assessment (SOFA) score after the intervention, checking for possible reduction in organ dysfunction, analyzed daily score assessment;Assess the changes in body electrical impedance through bioimpedance after applying transcutaneous photobiomodulation, analyzed using the InbodyS10 equipment;Evaluate the changes in skin microcirculation at the site of transcutaneous photobiomodulation application after the intervention, analyzed using a laser doppler;To assess the changes in skin temperature in the area where transcutaneous photobiomodulation is applied during the follow-up period, analyzed using a thermal imaging camera

Countries

BR

Contacts

Public ContactGabrielli Zavatieri

Hospital das clínicas da Faculdade de medicina de Ribeirão Preto

gfzavatieri@hcrp.usp.br+55 (16) 993878394

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Aug 10, 2026